X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - WN.COM - Health - 16/Sep 06:31

Newron presents H1 2025 results and provides business update

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Half Year Results Newron presents H1 2025 results and provides business update 16.09.2025 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Newron presents H1 2025 results and provides business update Milan, Italy, September 16, 2025, 07:00 am CEST – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced its financial results and operational highlights for the half-year ended June 30, 2025, and provided a business update...

Articles similaires

Sorry! Image not available at this time

Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report

wn.com - 17/Sep 08:03

MONTPELLIER, France--(BUSINESS WIRE)--Sep 17, 2025-- ......

Sorry! Image not available at this time

Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report

wn.com - 17/Sep 08:03

MONTPELLIER, France--(BUSINESS WIRE)--Sep 17, 2025-- ......

Sorry! Image not available at this time

Kistos provides trading and operational update

energy pedia.com - 10/Sep 07:53

Kistos, an independent energy company focused on generating value across the upstream and midstream markets, has provided a trading and operational...

Sorry! Image not available at this time

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

healthtechzone.com - 17/Sep 20:05

Sorry! Image not available at this time

Club Med Continues to Deliver Steady Growth, Half Year Results Indicate

ittn.ie - 19/Sep 09:27

Club Med achieves record breaking company business volume of €1,175 million for H1 2025, against a backdrop of economic and geopolitical...

Sorry! Image not available at this time

aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year

wn.com - 19/Sep 21:40

EQS-News: aap Implantate AG / Key word(s): Personnel aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will...

Sorry! Image not available at this time

aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year

wn.com - 19/Sep 21:40

EQS-News: aap Implantate AG / Key word(s): Personnel aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will...

Sorry! Image not available at this time

Innate Pharma Reports First Half 2025 Business Update and Financial Results

wn.com - 17/Sep 08:03

MARSEILLE, France--(BUSINESS WIRE)--Sep 17, 2025-- ......

Sorry! Image not available at this time

Innate Pharma Reports First Half 2025 Business Update and Financial Results

wn.com - 17/Sep 08:03

MARSEILLE, France--(BUSINESS WIRE)--Sep 17, 2025-- ......

Sorry! Image not available at this time

Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report

mangaloremirror.com - 17/Sep 05:41

Achieved expedited enrollment completion of first two Cohorts in Phase 1/2 Audiogene clinical trial evaluating SENS-501, the Company’s gene therapy...

Les derniers communiqués